Abcam plc(ABCM)
Search documents
Abcam plc(ABCM) - 2022 Q4 - Earnings Call Transcript
2023-03-20 15:52
State Bank of India ADR (NASDAQ:ABCM) Q4 2022 Earnings Conference Call March 20, 2023 8:00 AM ET Company Participants Tommy Thomas - Vice President of Investor Relations Alan Hirzel - Chief Executive Officer Michael Baldock - Chief Financial Officer Conference Call Participants Tejas Sevant - Morgan Stanley Puneet Souda - SBV Securities Matt Larew - William Blair Michael Ryskin - Bank of America Charles Weston - RBC Justin Bowers - Deutsche Bank Operator Hello, and welcome to the Abcam plc Full-Year 2022 Ea ...
Abcam plc(ABCM) - 2023 Q1 - Quarterly Report
2023-03-20 11:05
Exhibit 99.1 ABCAM PLC Final results for the year ended 31 December 2022 15% Reported Revenue Growth & 8% Constant Exchange Rate Revenue Growth: Demand for Abcam In-house Products Continues 20 March 2023, Cambridge, UK – Abcam plc (Nasdaq: ABCM) (‘Abcam’, the ‘Group’ or the ‘Company’), a global leader in the supply of life science research tools, today announces its results for the year ended 31 December 2022 (the ‘period’). SUMMARY PERFORMANCE Year-End 31 December 2022 2021 £m £m Revenue 361.7 315.4 Gross ...
Abcam plc(ABCM) - 2022 Q4 - Annual Report
2023-03-20 11:01
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to OR ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SE ...
Abcam plc(ABCM) - 2022 Q3 - Quarterly Report
2022-09-11 16:00
Exhibit 99.1 ABCAM PLC Interim results for the six-month period ended 30 June 2022 20% constant exchange rate revenue growth in H1: Demand for Abcam In-house Products Increases 12 September 2022, Cambridge, UK – Abcam plc (Nasdaq: ABCM; AIM: ABC) ('Abcam', the 'Group' or the 'Company'), a global leader in the supply of life science research tools, today announces its interim results for the six-month period ended 30 June 2022 (the 'period'). FINANCIAL PERFORMANCE | --- | --- | --- | |----------------------- ...
Abcam plc(ABCM) - 2021 Q4 - Earnings Call Transcript
2022-03-14 16:38
Abcam plc (NASDAQ:ABCM) Q4 2021 Earnings Conference Call March 14, 2022 9:00 AM ET Company Participants Alan Hirzel - CEO Michael S. Baldock - CFO James Stavely - VP, IR Conference Call Participants Puneet Souda - SVB Leerink Tejas Sevant - Morgan Stanley Stefan Hamill - Numis Matt Larew - William Blair Charles Weston - RBC Capital Markets Michael Ryskin - Bank of America Miles Dixon - Peel Hunt Operator Ladies and gentlemen, welcome to the AbcamÂ's Full Year Results Conference Call for the 12 and 18 Month ...
Abcam plc(ABCM) - 2021 Q4 - Earnings Call Presentation
2022-03-14 12:19
abcam 人 Abcam plc Full Year Results [12 and 18 months to 31 December 2021 Y 14 March 2022 Abcam plc | Full Year results for the 12 and 18 month periods ended 31 December 2021 | 14 March 2022 Disclaimer Forward-looking statements Thịs presentation contains forward-looking statements. which are bosed upon current expectations ond cosumption gegarging antigozted deyelopments ond oher nocher nocher (r "anticipate," "intend," "seek," "believe," "estimale," "predict," "potential," "continue," "continue," "possibl ...
Abcam plc(ABCM) - 2021 Q4 - Annual Report
2022-03-14 12:12
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to OR ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF ...
Abcam plc(ABCM) - 2022 Q1 - Quarterly Report
2022-03-13 16:00
Exhibit 99.1 Abcam Plc Results for the 12- and 18-month periods ended 31 December 2021 Growing demand for Abcam's portfolio of in-house products drives calendar 2021 revenues up by 22% at constant exchange rates Acquisition of BioVision completed 26 October 2021 CAMBRIDGE, United Kingdom, March 14, 2022 (GLOBE NEWSWIRE) – Abcam plc (Nasdaq: ABCM; AIM: ABC) ('Abcam', the 'Group' or the 'Company'), a global leader in the supply of life science research tools, today announces its final results for the 18-month ...
Abcam plc(ABCM) - 2020 Q4 - Annual Report
2021-09-01 11:26
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☐ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended OR ☒ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from July 1, 2020 to December 31, 2020 OR ☐ SHELL COMPANY REPORT PUR ...